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Summary
TNF receptor 1 (TNFR1) can trigger opposing re-
sponses within the same cell: a prosurvival response
or a cell-death pathway [1, 2]. Cell survival requires
NF-kB-mediated transcription of prosurvival genes
[3–9]; apoptosis occurs if NF-kB signaling is blocked
[5, 7–9]. Hence, activation of NF-kB acts as a cell-death
switch during TNF signaling. This study demonstrates
that the pathway includes another cell-death switch
that is independent of NF-kB. We show that lysine
63-linked ubiquitination of RIP1 on lysine 377 inhibits
TNF-induced apoptosis first through an NF-kB-inde-
pendent mechanism and, subsequently, through an
NF-kB-dependent mechanism. In contrast, in the ab-
sence of ubiquitination, RIP1 serves as a proapoptotic
signaling molecule by engaging CASPASE-8. There-
fore, RIP1 is a dual-function molecule that can be
either prosurvival or prodeath depending on its ubiq-
uitination state, and this serves as an NF-kB-indepen-
dent cell-death switch early in TNF signaling. These
results provide an explanation for the conflicting re-
ports on the role of RIP1 in cell death; this role was
previously suggested to be both prosurvival and pro-
death [10–12]. Because TRAF2 is the E3 ligase for
RIP1 [13], these observations provide an explanation
for the NF-kB-independent antiapoptotic function
previously described for TRAF2 [14–16].
Results and Discussion
TNFR1 ligation can induce the prosurvival NF-kB path-
way or the cell-death pathway. The molecular mecha-
nism that determines which of these two opposing
signaling pathways is triggered is unclear. Lysine 377
of RIP1 was recently shown to be an acceptor site for
K63-linked polyubiquitination, and this mediates effi-
cient NF-kB activation by TNF ([17, 18] and Figure S1 in
the Supplemental Data available online). Whether ubiqui-
tination of lysine 377 regulates the opposing cell-death
pathway has not been fully examined. To do so, we quan-
tified TNF-induced apoptosis in RIP1-null Jurkat cells
or RIP1-null cells reconstituted with RIP1-WT or RIP1-
*Correspondence: adrian.ting@mssm.eduK377R. After 5 hr of TNF treatment, there was no signifi-
cant difference in the amount of apoptosis of RIP1-null or
RIP1-WT cells (Figure 1A and Figure S1D). This compar-
ison did not reveal a role for RIP1 in apoptosis. However,
a comparison of the RIP1-K377R cells to the RIP1-WT
cells showed a clear enhancement in sensitivity to
TNF-mediated killing in RIP1-K377R cells, suggesting
that ubiquitination of RIP1 serves to inhibit apoptosis.
The surprising observation was that RIP1-K377R cells
are more sensitive to apoptosis even though they acti-
vate more NF-kB than RIP1-null cells (Figures S1A and
S1B). This suggests that ubiquitination of lysine 377 at
this early time point has an antiapoptotic effect that
may be independent of NF-kB because there is no corre-
lation between induction of NF-kB signaling and sensi-
tivity to apoptosis. After 24 hr of TNF stimulation, the
RIP1-K377R cells remained more susceptible to TNF-
mediated killing than RIP1-null cells. However, the
RIP1-WT cells were then less susceptible than RIP1-
null cells, suggesting that upon prolonged stimulation,
RIP1-WT provides an additional antiapoptotic signal
(Figure 1A). A time-course experiment showed that
RIP1-K377R cells have a discernable enhancement in
sensitivity to apoptosis in comparison to either RIP1-
null or RIP1-WT cells by 4 hr, and this enhancement per-
sisted for the duration of the experiment (Figure 1B). The
resistance of the RIP1-WT cells to apoptosis in compar-
ison to RIP1-null cells was not apparent during the first
12 hr but is discernable after 24 hr. Thus, ubiquitination
of RIP1 on lysine 377 appears to provide at least two
distinct survival signals: one that is apparent after a short
period of receptor ligation and a second one that is
evident only after prolonged stimulation.
TNF-mediated apoptosis requires CASPASE-8, which
initiates cleavage and activation of the executioner cas-
pase, CASPASE-3, to cleave substrates including poly
(ADP Ribose) polymerase (PARP). RIP1-K377R cells
exhibit faster CASPASE-8 processing to the active p18
fragment and enhanced CASPASE-3 and PARP cleav-
age in comparison to RIP1-WT cells (Figure 1C, left
panel). Consistent with the time-course experiment,
more CASPASE-8, -3, and PARP cleavage were ob-
served in response to increasing concentrations of
TNF in the RIP1-K377R cells (Figure 1C, right panel).
Therefore, the enhanced apoptosis observed in RIP1-
K377R cells compared to RIP1-WT cells (Figure 1A) is
due to increased activation of caspases upon TNFR1
ligation.
We next hypothesized that NF-kB activation is not re-
quired for the early prosurvival signal mediated by RIP1’s
ubiquitination but that the second prosurvival signal is
dependent on NF-kB transcription factors. We tested
these hypotheses by blocking NF-kB activation in
RIP1-null, RIP1-WT, and RIP1-K377R cells by stable
transfection of the IkBaSR (Figure S2). NF-kB blockade
had no effect on the sensitivity of the three different cell
lines to apoptosis after a short TNF stimulation of 5 hr;
the RIP1-K377R cells remained more sensitive to
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419Figure 1. Lysine 377 of RIP1 Regulates Cell Death
(A) RIP1-null cells and RIP1-null cells reconstituted with RIP1-WT or RIP1-K377R were stimulated with the indicated doses of TNF for 5 and 24 hr.
Cells were stained with annexin V-PE and analyzed by flow cytometry. The percentage of total cells that were reactive to annexin V is shown.
(B) The three cell lines in (A) were stimulated with 10 ng/ml TNF for the indicated times, and annexin-V levels were analyzed.
(C) RIP1-WT and RIP1-K377R cells were stimulated with 10 ng/ml TNF for different periods of time (left panel) or the indicated doses of TNF for
24 hr (right panel). Cell lysates were blotted with antibodies specific for CASPASE-8, cleaved CASPASE-3, or cleaved PARP. The anti-PARP blots
were also overexposed to visualize additional PARP cleavage products. Reblotting with anti-tubulin and PLCg demonstrated equivalent loading.
These western blots are representative of at least three similar experiments.apoptosis than the RIP1-null and RIP1-WT cells in the
presence of the IkBaSR (Figure 2A, panels I and II and
Figure S2C). Therefore, we conclude that the enhanced
sensitivity in the RIP1-K377R cells is not due to its re-
duced capacity to activate the NF-kB signaling pathway.
Rather, this reflects the loss of an NF-kB-independent
antiapoptotic signal in the RIP1-K377R cells; this loss
is consistent with the hypothesis that ubiquitination of
RIP1 provides an NF-kB-independent antiapoptotic sig-
nal early in TNFR1 signaling. Next, we analyzed the effect
of NF-kB blockade after a prolonged 24 hr stimulation
with TNF. In the presence of the IkBaSR, both the
RIP1-null and RIP1-WT cells were equally sensitive to
TNF-mediated apoptosis (Figure 2A, panel IV and Fig-
ure S2C), confirming that the second, delayed antiapop-
totic effect of RIP1-WT is dependent on NF-kB signaling.
Moreover, the continued heightened sensitivity of the
RIP1-K337R cells to apoptosis after extended TNF stim-
ulation indicates the NF-kB independence of the early
antiapoptotic effect of RIP1 ubiquitination.We performed a time-course experiment to determine
the kinetic relationship of the two antiapoptosis signals
(Figure 2B). In both the control and the IkBaSR-trans-
fected cells, we consistently observed enhanced apo-
ptosis in the RIP1-K377R cells as of 4 hr after stimulation,
indicating that the initial NF-kB-independent antiapop-
totic signal was having an effect by that time. Consistent
with the time-course experiment in Figure 1B, the sensi-
tivity of the RIP1-WT and RIP1-null cells only showed
a difference after 24 hr (Figure 2B, panel I). This prosur-
vival effect of RIP1-WT was abrogated in the presence
of IkBaSR (Figure 2B, panel II). Thus, the NF-kB-depen-
dent antiapoptotic signal generated by RIP1 comes
into effect only after prolonged stimulation. This kinetic
analysis confirms that ubiquitination of RIP1 on lysine
377 provides first an antideath signal that is independent
of NF-kB, and this signal is then followed by one that
is dependent on NF-kB. To gain insight into whether
the NF-kB-independent antiapoptotic signal inhibits
caspases, we compared CASPASE-8, -3, and PARP
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420Figure 2. Lysine 377 of RIP1 Provides an Early NF-kB-Independent and a Late NF-kB-Dependent Antiapoptotic Signal
(A) RIP1-null, RIP1-WT, or RIP1-K377R cells were transduced with retroviruses encoding either GST as a negative control (left panels) or IkBaSR
(right panels). These cells were stimulated with the indicated doses of TNF for 5 hr (panels I and II) and 24 hr (panels III and IV). Apoptosis was
analyzed by annexin V staining and flow cytometry as in Figure 1A.
(B) The cell lines in (A) were stimulated with 10 ng/ml TNF, and apoptosis was analyzed at the indicated times.
(C) RIP1-WT and RIP1-K377R cells stably transfected with the Myc-tagged IkBaSR were stimulated with the indicated doses of TNF for 24 hr
(right panel) or 10 ng/ml TNF for different periods of time (left panel). Cell lysates were blotted as in Figure 1C. The anti-Myc blot both serves
as a loading control and shows equivalent expression of the IkBaSR in the two cell lines. These western blots are representative of at least three
similar experiments.cleavage in the RIP1-WT and RIP1-K377R cells trans-
fected with the IkBaSR. The RIP1-K377R/IkBaSR cells
showed enhanced cleavage in a time- and dose-depen-
dent manner (Figure 2C). Therefore, the NF-kB-indepen-
dent, antiapoptosis signal provided by ubiquitination of
lysine 377 of RIP1 inhibits the activation of CASPASE-8.
Loss-of-function of TRAF2 (the E3 ligase for RIP1 [13])
or its upstream E2 ubiquitin-conjugating enzyme UBC13
[19] should result in the same phenotype, i.e., enhanced
apoptosis in an NF-kB-independent manner, as the loss
of the K377 ubiquitin acceptor site. The IKKg-deficient
Jurkat T cell line 8321, which lacks NF-kB signaling
[20], was transduced with a dominant-negative mutant
of TRAF2 (TRAF2DN) or UBC13 (UBC13DN). As pre-
dicted, the TRAF2DN- and UBC13DN-expressing cells
are both more sensitive to apoptosis than control cells
after either 5 or 24 hr of TNF treatment (Figure 3A). In
agreement with this, more activation of the caspase cas-
cade was observed in the TRAF2DN and UBC13DN cells
compared to the negative control in a dose-dependent
(Figure S3A) and time-dependent manner (Figure 3B).
Consistent with published studies [14–16], Traf22/2
MEFs also exhibited similar NF-kB-independent en-
hancements in apoptosis (Figure S4). We conclude that
K63-linked ubiquitination of RIP1 by UBC13 and TRAF2
provides an NF-kB-independent antiapoptotic signal.
Conversely, the loss of K63-linked ubiquitination, either
through blockade of the E2 and E3 ligase or through
the loss of the ubiquitin acceptor site on RIP1, generates
a prodeath signal.The observations up to this point suggest that TRAF2
loss-of-function enhances apoptosis because RIP1
becomes a death-signaling molecule in the absence of
ubiquitination. If so, TRAF2 loss-of-function should
have less of an effect in RIP1-null cells than in RIP1-
sufficient cells. We expressed the TRAF2DN in both the
RIP1-null and RIP1-WT cell lines. After either 5 or 24 hr
of stimulation, the RIP1-null/TRAF2DN cells clearly dis-
played lower sensitivity to apoptosis than the RIP1-
WT/TRAF2DN cells (Figure 3C). Therefore, TRAF2 loss-
of-function potentiates cell death in a RIP1-dependent
manner. The 24 hr experiment further highlights the
dual functionality of RIP1. In control-transfected cells,
the presence of RIP1 confers protection against apopto-
sis, whereas in TRAF2DN-transfected cells, the pres-
ence of RIP1 confers sensitivity to apoptosis (Figure 3D).
Lastly, we hypothesized that ubiquitination of RIP1
or the lack thereof may regulate its interaction with
CASPASE-8 because of a report showing a direct inter-
action between the PRO domain of CASPASE-8 and
RIP1 [21]. Furthermore, CASPASE-8 can cleave RIP1,
and this finding is also suggestive of a direct interaction
[22–24]. We carried out coimmunoprecipitation studies
to test this hypothesis. In RIP1-WT cells, a low level of
RIP1-PROCASPASE-8 interaction was observed, and
this was not altered upon TNF stimulation. In contrast,
there is a stimulus-dependent association of PROCAS-
PASE-8, as well as processed CASPASE-8, with RIP1
in the RIP1-K377R cells (Figure 4A). Therefore, ubiquiti-
nation of RIP1 prevents RIP1 from forming a complex
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421Figure 3. UBC13 and TRAF2 Have an NF-kB-Independent Antiapoptotic Function
(A) IKKg/NEMO-deficient Jurkat T cells stably expressing the control protein GST, UBC13DN, or TRAF2DN were treated with the indicated
concentrations of TNF for 5 and 24 hr. Apoptosis was analyzed by annexin V staining.
(B) The cell lines in (A) were treated with 2 ng/ml of TNF for the indicated times. Cell extracts (150 mg) were analyzed by western blot as in
Figure 1C. Anti-ZAP70 blotting confirmed equivalent loading.
(C) RIP1-null or RIP1-WT cells were transduced with control GST or TRAF2DN-encoding retroviruses. Stably selected cells were treated with
indicated concentrations of TNF for 5 or 24 hr and stained with annexin V-PE.
(D) The data from (C) where the cells were stimulated with 5 ng/ml TNF for 24 hr are plotted in a bar graph to highlight the dual role of RIP1.with CASPASE-8. Conversely, in the absence of ubiquiti-
nation, RIP1 is able to form a complex with CASPASE-8
to initiate apoptosis.
The observations presented here indicate that RIP1 is
a dual-functional signaling molecule that is capable of ei-
ther prosurvival or prodeath signaling depending on its
ubiquitination state. We propose a model in which
RIP1, ubiquitinated by TRAF2 on lysine 377, provides
two distinct antiapoptotic signals (Figure 4B). The first
antiapoptotic signal occurs early after receptor ligation
to prevent RIP1 from complexing with CASPASE-8 and
is not dependent on the NF-kB pathway. The second
antiapoptotic signal emerges at a later time point, and
it is dependent on NF-kB-mediated upregulation of anti-
apoptotic genes such as c-FLIP. In the absence of ubiq-
uitination, RIP1 converts to a death-signaling molecule
that actively engages CASPASE-8 independently of its
effect on NF-kB signaling. Because ubiquitination of
RIP1 occurs prior to the induction of NF-kB-mediated
gene transcription and can regulate cell death in an
NF-kB-independent manner, we propose that the ubiq-
uitination status of lysine 377 is a cell-death decision
switch early in TNF signaling.
The role of RIP1 in TNF-mediated apoptosis has been
controversial, with reports of either prosurvival or pro-
death effects [10–12]. Our observation that RIP1 can
generate either prosurvival or prodeath signals depend-
ing on the ubiquitination state of lysine 377 provides an
explanation for these conflicting reports. It is also well
appreciated that TRAF2 has an NF-kB-independent
antiapoptotic function [14–16, 25], but the underlyingmechanism has been unclear. Our results now suggest
that the antiapoptotic function of TRAF2 is due in part
to its ubiquitination of RIP1, which acts as a brake on
the prodeath effect of RIP1. The results described here
raise the possibility that altering the ubiquitination state
of RIP1 will influence cell survival, which can be achieved
physiologically by altering the level of TRAF2 in the cell.
In this regard, stimulation of TNFR2 is known to lead
to TRAF2 degradation [12, 26, 27] and to potentiate
TNFR1-mediated cell death in a RIP1-dependent man-
ner [12, 28]. It is likely that in cells that express both
TNFR1 and TNFR2, TRAF2 degradation triggered by
TNFR2 creates a situation akin to the RIP1-K377R muta-
tion, which then enables TNFR1 to engage the apoptotic
cascade more efficiently via nonubiquitinated RIP1.
The observations in this study raise additional ques-
tions regarding the regulation of the RIP1-dependent
apoptotic pathway. For instance, because only a fraction
of the total pool of RIP1 in a wild-type cell is ubiquitinated
in response to TNF, why isn’t the nonubiquitinated pool
of RIP1 interacting with CASPASE-8? Because these
death-signaling molecules are constitutively expressed
in cells, it is in the interest of the cell to prevent these in-
teractions from occurring in unstimulated cells. These
preventive mechanisms are poorly understood and
could involve differential subcellular localization of the
molecules, the requirement for posttranslational modifi-
cations or conformational changes for the interactions to
occur, or the presence of inhibitors bound to RIP1 and
CASPASE-8. In the case of RIP1, it is likely that only
a fraction of the total RIP1 is released from inhibition to
Current Biology
422Figure 4. Ubiquitination of RIP1 Regulates Association with CASPASE-8
(A) RIP1-WT and RIP1-K377R cells were stimulated with 10 ng/ml TNF for the indicated times. FLAG-tagged RIP1 and associated proteins
were immunoprecipitated with anti-FLAG beads and eluted with the FLAG peptide. The immune complexes were blotted sequentially with
anti-CASPASE-8 and anti-RIP1 as a loading control. The anti-CASPASE-8 blot was also overexposed so that the p43/p41 cleaved form could
be visualized.
(B) A model for the role of RIP1 in TNF-mediated apoptosis. (I) In the early phase of TNFR1 signaling, TRAF2-mediated ubiquitination of lysine 377
functions as a brake to prevent RIP1 from associating with CASPASE-8. This does not require NF-kB-mediated gene transcription. (II) In the late
phase of TNFR1 signaling, a second prosurvival signal provided by the ubiquitination of lysine 377 becomes effective via the upregulation of
NF-kB-dependent antiapoptotic genes such as c-FLIP. (III) In the absence of K63-linked polyubiquitination, RIP1 becomes a death-signaling
molecule by forming a complex with CASPASE-8 to initiate apoptosis. Red indicates antiapoptotic molecules, and green indicates proapoptotic
molecules.become active, whereas the rest of the pool remains in an
inactive state and does not interact with CASPASE-8. It
has been shown that RIP1 is recruited to TNFR1 in bothTraf2+/+ and Traf22/2 cells [29], suggesting that ubiquiti-
nation is not required for this process. The receptor-
associated RIP1 may therefore constitute the active pool
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423of RIP1. The observation that RIP1-WT fails to form
a complex with CASPASE-8 whereas RIP1-K377R is
able to do so also raises the question as to how the ubiq-
uitination status of RIP1 determines its association with
CASPASE-8. One possibility is that RIP1 molecules re-
cruited to the receptor are retained at the plasma mem-
brane if they undergo ubiquitination via ubiquitin-depen-
dent binding to molecules such as TAB2/3 and IKKg [17,
18, 30]. In the absence of ubiquitination, RIP1 molecules
recruited to the receptor are not retained at the plasma
membrane and may now translocate to the cytosolic
compartment where CASPASE-8 is located. Alterna-
tively, ubiquitination of RIP1 may block its interaction
with CASPASE-8 via steric hindrance, either because of
the polyubiquitin chains themselves or because binding
of IKKg and TAB2/3 to the polyubiquitin chains prevents
CASPASE-8 from binding. These possibilities are cur-
rently being investigated.
Although the initial antiapoptotic signal provided by
ubiquitination of RIP1 does not require NF-kB signaling,
it is likely that NF-kB-mediated gene transcription can
modulate this ubiquitination event. For instance, NF-kB
induces several ubiquitin-modifying proteins, including
TRAF2, c-IAPs, A20, and CYLD [3, 31, 32]. Some of these
molecules are known to interact with RIP1, and therefore
the net amount of ubiquitination on lysine 377 is likely to
be dependent on the levels and activity of these mole-
cules. As we have shown in this report, the level of ubiq-
uitination on this critical lysine residue in turn determines
whether the net outcome is survival or death.
Supplemental Data
Supplemental Data include Experimental Procedures and four fig-
ures and are available online at http://www.current-biology.com/
cgi/content/full/17/5/418/DC1/.
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